FDA Accelerates Action on Treatments for Serious Mental Illness Following Executive Order

https://www.fda.gov/news-events/press-announcements/fda-accelerates-action-treatments-serious-mental-illness-following-executive-order

Agency issues priority vouchers, clears new clinical research, and advances guidance to support treatments for depression, PTSD, and substance use disorders

Next
Next

Psilocybin, in 10mg or 25mg doses, has no short- or long-term detrimental effects in healthy people. Link: